HB0017: Clinical Trials

3 trials of HB0017, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1

Follow HB0017: new trials by email Literature Review of HB0017 trials Research Report on HB0017

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2 Study of HB0017 in Psoriasis Patients
HB0017 - Psoriasis (PsO)
Phase 2CompletedHuabo Biopharm Co., Ltd.2062024-09-302026-10-23
A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis
Placebo, HB0017 - Plaque Psoriasis
Phase 2CompletedHuabo Biopharm Co., Ltd.1602022-10-252024-06-21
A Study of Injection HB0017 in Adult Healthy Volunteers
HB0017, placebo - Healthy Subjects
Phase 1CompletedHuabo Biopharm Co., Ltd.402020-10-022021-07-28

Conditions studied

Psoriasis (1)

Sponsors

Huabo Biopharm Co., Ltd. (3)

Countries

China (2)  ·  New Zealand (1)

Results publications

PMID 37669307